Abstract:Motivation: Computational drug repositioning is an important and efficient approach towards identifying novel treatments for diseases in drug discovery. The emergence of large-scale, heterogeneous biological and biomedical datasets has provided an unprecedented opportunity for developing computational drug repositioning methods. The drug repositioning problem can be modeled as a recommendation system that recommends novel treatments based on known drug-disease associations. The formulation under this recommendation system is matrix completion, assuming that the hidden factors contributing to drug-disease associations are highly correlated and thus the corresponding data matrix is low-rank. Under this assumption, the matrix completion algorithm fills out the unknown entries in the drug-disease matrix by constructing a low-rank matrix approximation, where new drug-disease associations having not been validated can be screened.Results: In this work, we propose a drug repositioning recommendation system (DRRS) to predict novel drug indications by integrating related data sources and validated information of drugs and diseases. Firstly, we construct a heterogeneous drug-disease interaction network by integrating drug-drug, disease-disease and drug-disease networks. The heterogeneous network is represented by a large drug-disease adjacency matrix, whose entries include drug pairs, disease pairs, known drug-disease interaction pairs and unknown drug-disease pairs. Then, we adopt a fast Singular Value Thresholding (SVT) algorithm to complete the drug-disease adjacency matrix with predicted scores for unknown drug-disease pairs. The comprehensive experimental results show that DRRS improves the prediction accuracy compared with the other state-of-the-art approaches. In addition, case studies for several selected drugs further demonstrate the practical usefulness of the proposed method.Availability and implementation: http://bioinformatics.csu.edu.cn/resources/softs/DrugRepositioning/DRRS/index.html.Contact: yaohang@cs.odu.edu or jxwang@mail.csu.edu.cn.Supplementary information: Supplementary data are available at Bioinformatics online.

Revisiting Drug Recommendation From a Causal Perspective

MoleRec: Combinatorial Drug Recommendation with Substructure-Aware Molecular Representation Learning

DrugDoctor: enhancing drug recommendation in cold-start scenario via visit-level representation learning and training

MGRN: toward robust drug recommendation via multi-view gating retrieval network

CIDGMed: Causal Inference-Driven Medication Recommendation with Enhanced Dual-Granularity Learning

Knowledge-Driven New Drug Recommendation

Computational drug repositioning using low-rank matrix approximation and randomized algorithms

MGEDR: A Molecular Graph Encoder for Drug Recommendation

DRIMC: an improved drug repositioning approach using Bayesian inductive matrix completion

CausalMed: Causality-Based Personalized Medication Recommendation Centered on Patient health state

Drug Package Recommendation via Interaction-aware Graph Induction

Medication Recommendation via Dual Molecular Modalities and Multi-Step Enhancement

Computational Approaches for Predicting Drug-Disease Associations: A Comprehensive Review

Deep Causal Reasoning for Recommendations

Bayesian multitask learning for medicine recommendation based on online patient reviews

Sequential Recommendation with Causal Behavior Discovery

A Drug Recommendation Model Based on Message Propagation and DDI Gating Mechanism

AKA-SafeMed: A safe medication recommendation based on attention mechanism and knowledge augmentation

4Sdrug: Symptom-based Set-to-set Small and Safe Drug Recommendation

MRNDR: Multihead Attention-Based Recommendation Network for Drug Repurposing

When deep learning meets causal inference: a computational framework for drug repurposing from real-world data